Literature DB >> 22246785

Nationwide survey of nevoid basal cell carcinoma syndrome in Japan revealing the low frequency of basal cell carcinoma.

Mamiko Endo1, Katsunori Fujii, Katsuo Sugita, Kayoko Saito, Yoichi Kohno, Toshiyuki Miyashita.   

Abstract

Nevoid basal cell carcinoma syndrome (NBCCS) is characterized by developmental defects and tumorigenesis. The clinical manifestations of NBCCS have been reported in large epidemiological studies from the United States, the United Kingdom, and Australia, but not from an Asian country. We conducted a nationwide survey and identified 311 NBCCS patients in Japan. We investigated the detailed clinical manifestations of 157 patients ranging in age from 9 months to 77 years old (mean: 33.1 years). We then compared the frequency and age of onset for various tumors developed in Japanese NBCCS patients with patients from the three countries listed above in which NBCCS studies were previously conducted. Our most significant finding was the low frequency of basal cell carcinoma (BCC) in Japanese patients. Frequency of BCC in patients over 20 years of age was 51.4%, a much lower rate compared to the United States, Australia, and the United Kingdom (91%, 85%, and 73%, respectively). The mean age of BCC onset was 37.4 years of age, a much older age compared to the above-mentioned countries. These findings suggest that differences in ethnicity and/or environmental factors affect the incidence of BCC. Because the age of BCC onset is generally higher in Japanese NBCCS patients, careful skin examination over a prolonged period of time is warranted.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22246785     DOI: 10.1002/ajmg.a.34421

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  24 in total

1.  Frameshift mutation in the PTCH2 gene can cause nevoid basal cell carcinoma syndrome.

Authors:  Katsunori Fujii; Hirofumi Ohashi; Maiko Suzuki; Hiromi Hatsuse; Tadashi Shiohama; Hideki Uchikawa; Toshiyuki Miyashita
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

2.  Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation.

Authors:  Chihiro Kijima; Toshiyuki Miyashita; Maiko Suzuki; Hidehiro Oka; Kiyotaka Fujii
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

Review 3.  A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.

Authors:  Sarah Scollon; Amanda Knoth Anglin; Martha Thomas; Joyce T Turner; Kami Wolfe Schneider
Journal:  J Genet Couns       Date:  2017-03-29       Impact factor: 2.537

4.  Nevoid basal cell carcinoma syndrome caused by splicing mutations in the PTCH1 gene.

Authors:  Chise Kato; Kentaro Fujii; Yuto Arai; Hiromi Hatsuse; Kazuaki Nagao; Yoshinaga Takayama; Kouzou Kameyama; Katsunori Fujii; Toshiyuki Miyashita
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

Review 5.  Sonic hedgehog signaling in Basal cell nevus syndrome.

Authors:  Mohammad Athar; Changzhao Li; Arianna L Kim; Vladimir S Spiegelman; David R Bickers
Journal:  Cancer Res       Date:  2014-08-29       Impact factor: 12.701

Review 6.  Review of Ocular Manifestations of Nevoid Basal Cell Carcinoma Syndrome: What an Ophthalmologist Needs to Know.

Authors:  Judy J Chen; Juliana Sartori; Vinay K Aakalu; Pete Setabutr
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Oct-Dec

7.  Genomic profiling of late-onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndrome.

Authors:  O Hasan Ali; A A Yurchenko; O Pavlova; A Sartori; D Bomze; R Higgins; S S Ring; F Hartmann; D Bühler; F R Fritzsche; W Jochum; A A Navarini; A Kim; L E French; E Dermitzakis; A M Christiano; D Hohl; D R Bickers; S I Nikolaev; L Flatz
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-23       Impact factor: 6.166

8.  Novel PTCH1 mutations in patients with keratocystic odontogenic tumors screened for nevoid basal cell carcinoma (NBCC) syndrome.

Authors:  Lorenza Pastorino; Annamaria Pollio; Giovanni Pellacani; Carmelo Guarneri; Paola Ghiorzo; Caterina Longo; William Bruno; Francesca Giusti; Sara Bassoli; Giovanna Bianchi-Scarrà; Cristel Ruini; Stefania Seidenari; Aldo Tomasi; Giovanni Ponti
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

Review 9.  Vismodegib hedgehog-signaling inhibition and treatment of basal cell carcinomas as well as keratocystic odontogenic tumors in Gorlin syndrome.

Authors:  Patrick Booms; Marc Harth; Robert Sader; Shahram Ghanaati
Journal:  Ann Maxillofac Surg       Date:  2015 Jan-Jun

10.  A clinicopathological survey of Basal cell carcinoma in an Iranian population.

Authors:  M Zargaran; A Moghimbeigi; Ar Monsef; H Teimourian; S Shojaei
Journal:  J Dent (Shiraz)       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.